Literature DB >> 23747102

Vaccination with LiESP/QA-21 (CaniLeish®) reduces the intensity of infection in Phlebotomus perniciosus fed on Leishmania infantum infected dogs--a preliminary xenodiagnosis study.

Gioia Bongiorno1, Rosa Paparcone, Valentina Foglia Manzillo, Gaetano Oliva, Anne-Marie Cuisinier, Luigi Gradoni.   

Abstract

Ten Beagle dogs at different stages of Leishmania infantum infection, among which 6 had received a full course of LiESP/QA-21 (CaniLeish(®); Virbac) vaccination, were exposed to the bites of reared Phlebotomus perniciosus to assesses their infectiousness potential. This was found to be negligible/nil in 2 seronegative dogs with subpatent infection. Among the 8 dogs with active infection (=positive serology, bone-marrow qualitative PCR and lymph node culture), 2/5 vaccinated (40.0%) and 2/3 nonvaccinated dogs (66.7%) were infectious to the sand flies (p=0.5). However significantly fewer of the sand flies which fed on the vaccinated dogs were infected when compared to those which fed on the control dogs (10/82 compared to 30/49) (chi-squared test, p<0.0001; mixed binomial model with the dog identity included as a random effect, p=0.03). Furthermore, there was a significant difference in the proportion of sand flies with >500 parasites in their gut (i.e. a higher risk for subsequent transmission): 3.7% for vaccinated dogs compared with 28.6% for nonvaccinated dogs (Fisher's exact test, p<0.0001; binomial mixed model, p=0.006). Although preliminary, these results suggest value in further investigations on L. infantum transmissibility parameters in LiESP/QA-21 vaccinated dogs.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Canine leishmaniosis; Leishmania infantum; LiESP/QA-21 vaccine; Phlebotomus perniciosus; Xenodiagnosis

Mesh:

Year:  2013        PMID: 23747102     DOI: 10.1016/j.vetpar.2013.05.008

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  22 in total

1.  WSAVA Guidelines for the vaccination of dogs and cats.

Authors:  M J Day; M C Horzinek; R D Schultz; R A Squires
Journal:  J Small Anim Pract       Date:  2016-01       Impact factor: 1.522

2.  Immunogenicity in dogs and protection against visceral leishmaniasis induced by a 14kDa Leishmania infantum recombinant polypeptide.

Authors:  Claudia Abeijon; Nada Daifalla; Greice Krautz-Peterson; Stefano Pizzirani; Gillian Beamer; Neuza M Frazatti-Gallina; Isaias Raw; Antonio Campos-Neto
Journal:  Trials Vaccinol       Date:  2016

3.  One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis.

Authors:  Christiane Costa-Pereira; Marcela L Moreira; Rodrigo P Soares; Bruno H Marteleto; Vitor M Ribeiro; Michelle H França-Dias; Ludmila M Cardoso; Kelvinson F Viana; Rodolfo C Giunchetti; Olindo A Martins-Filho; Márcio S S Araújo
Journal:  BMC Vet Res       Date:  2015-04-11       Impact factor: 2.741

4.  Canine Antibodies against Salivary Recombinant Proteins of Phlebotomus perniciosus: A Longitudinal Study in an Endemic Focus of Canine Leishmaniasis.

Authors:  Tatiana Kostalova; Tereza Lestinova; Petra Sumova; Michaela Vlkova; Iva Rohousova; Eduardo Berriatua; Gaetano Oliva; Eleonora Fiorentino; Aldo Scalone; Marina Gramiccia; Luigi Gradoni; Petr Volf
Journal:  PLoS Negl Trop Dis       Date:  2015-06-25

5.  Management of canine leishmaniosis in endemic SW European regions: a questionnaire-based multinational survey.

Authors:  Patrick Bourdeau; Manolis N Saridomichelakis; Ana Oliveira; Gaetano Oliva; Tina Kotnik; Rosa Gálvez; Valentina Foglia Manzillo; Alex F Koutinas; Isabel Pereira da Fonseca; Guadalupe Miró
Journal:  Parasit Vectors       Date:  2014-03-24       Impact factor: 3.876

6.  Recommendations on vaccination for Latin American small animal practitioners: a report of the WSAVA Vaccination Guidelines Group.

Authors:  M J Day; C Crawford; M Marcondes; R A Squires
Journal:  J Small Anim Pract       Date:  2020-03-30       Impact factor: 1.522

7.  Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice.

Authors:  Manuel Soto; Laura Corvo; Esther Garde; Laura Ramírez; Virginia Iniesta; Pedro Bonay; Carlos Gómez-Nieto; Víctor M González; M Elena Martín; Carlos Alonso; Eduardo A F Coelho; Aldina Barral; Manoel Barral-Netto; Salvador Iborra
Journal:  PLoS Negl Trop Dis       Date:  2015-05-08

Review 8.  Dogs, cats, parasites, and humans in Brazil: opening the black box.

Authors:  Filipe Dantas-Torres; Domenico Otranto
Journal:  Parasit Vectors       Date:  2014-01-14       Impact factor: 3.876

9.  Clinical and parasitological protection in a Leishmania infantum-macaque model vaccinated with adenovirus and the recombinant A2 antigen.

Authors:  Gabriel Grimaldi; Antonio Teva; Renato Porrozzi; Marcelo A Pinto; Renato S Marchevsky; Maria Gabrielle L Rocha; Miriam S Dutra; Oscar Bruña-Romero; Ana-Paula Fernandes; Ricardo T Gazzinelli
Journal:  PLoS Negl Trop Dis       Date:  2014-06-19

10.  The protective immune response produced in dogs after primary vaccination with the LiESP/QA-21 vaccine (CaniLeish®) remains effective against an experimental challenge one year later.

Authors:  Virginie Martin; Ioannis Vouldoukis; Javier Moreno; David McGahie; Sylvie Gueguen; Anne-Marie Cuisinier
Journal:  Vet Res       Date:  2014-06-25       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.